Lexpos News

Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Botulism caused by botulinum toxin is rare but can be life threatening. Symptoms can take up to four weeks to develop and may typically include difficulty breathing [...]

The post MHRA Drug Safety Update: Botulinum toxin type A products appeared first on Community Pharmacy England.

As announced previously the Government and connectivity providers have been advising community pharmacy owners and others to take action to prepare for the upcoming national switch-off of the Public Switched Telephone Network (PSTN), which is due to be fully decommissioned by January 2027. In a letter to the sector, the Department for Science, Innovation and [...]

The post Reminder: Pharmacies preparing for national digital phoneline switchover appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined May and June 2026 reimbursement prices for the following products to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed [...]

The post Retrospective reimbursement prices for May and June 2026 appeared first on Community Pharmacy England.

iNews, Daily Mail Community pharmacies across England are facing severe financial losses, with patients increasingly feeling the impact through delays to medicines and reduced access to care.   New survey findings from Community Pharmacy England show that daily medicines shortages and rising operating pressures are affecting both pharmacy teams and the people who rely on them.  [...]

The post 75% of pharmacies losing money as medicine shortages hit patients daily appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Nabilone 1mg capsules MSN/2026/032 Tier 2 – medium impact Date of issue: 14/07/2026 Summary Nabilone 1mg capsules are currently out of stock with an anticipated resupply date of end of August 2026 Nabilone 0.25mg capsules remain available [...]

The post Medicine Supply Notification: Nabilone 1mg capsules appeared first on Community Pharmacy England.